Home

Confuso piatto Colpevole sabcs 2018 posters gamba Infinito Natura

San Antonio Breast Cancer Symposium (SABCS) 2018 - DCIS Precision
San Antonio Breast Cancer Symposium (SABCS) 2018 - DCIS Precision

Puma Biotechnology Presents Final Overall Survival Analysis from the Phase  III ExteNET Trial at the 2020 SABCS | Business Wire
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS | Business Wire

AACR BluePrint HER2 Poster 2612 - Agendia
AACR BluePrint HER2 Poster 2612 - Agendia

Kelsey and Keighley present at SABCS | Taube Lab
Kelsey and Keighley present at SABCS | Taube Lab

Resource Library
Resource Library

2023 American Association For Cancer Research Annual, 49% OFF
2023 American Association For Cancer Research Annual, 49% OFF

Summary of Our Flat Closure Research from #SABCS19 - Not Putting on a Shirt
Summary of Our Flat Closure Research from #SABCS19 - Not Putting on a Shirt

What's new in breast cancer research? SABCS 2022 delivers plenty | Fred  Hutchinson Cancer Center
What's new in breast cancer research? SABCS 2022 delivers plenty | Fred Hutchinson Cancer Center

Lobular Research at the San Antonio Breast Cancer Symposium 2019 - The  Lobular Breast Cancer Alliance
Lobular Research at the San Antonio Breast Cancer Symposium 2019 - The Lobular Breast Cancer Alliance

New therapies unveiled at San Antonio breast cancer conference - San  Antonio Business Journal
New therapies unveiled at San Antonio breast cancer conference - San Antonio Business Journal

San Antonio Breast Cancer Symposium (SABCS) 2018! - Lee/Oesterreich  Laboratory
San Antonio Breast Cancer Symposium (SABCS) 2018! - Lee/Oesterreich Laboratory

JCEMS-Call for poster abstracts | PDF
JCEMS-Call for poster abstracts | PDF

Resource Library
Resource Library

Resource Library
Resource Library

The Top 5 Biosimilar Articles From SABCS 2020
The Top 5 Biosimilar Articles From SABCS 2020

Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III  Clinical Trial Design for Recurring Breast Cancer | Greenwich LifeSciences,  Inc. (GLSI) | GP2
Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer | Greenwich LifeSciences, Inc. (GLSI) | GP2

Scientific Presentations – Outliers – UW–Madison
Scientific Presentations – Outliers – UW–Madison

HR+/HER2- Advanced breast cancer: what are the latest developments in  CDK4/6 inhibition from the SABCS 2019? - touchONCOLOGY
HR+/HER2- Advanced breast cancer: what are the latest developments in CDK4/6 inhibition from the SABCS 2019? - touchONCOLOGY

San Antonio Breast Cancer Symposium > Home
San Antonio Breast Cancer Symposium > Home

Papers, Posters and Presentations | Seno Medical
Papers, Posters and Presentations | Seno Medical

MagSense® Pre-Clinical Study Presented at 2018 SABCS | Imagion Biosystems
MagSense® Pre-Clinical Study Presented at 2018 SABCS | Imagion Biosystems

I-SPY2 Presentations and Posters at SABCS 2018 [I-SPY Trials]
I-SPY2 Presentations and Posters at SABCS 2018 [I-SPY Trials]

2018 SABCS FLEX Trials in Progress Poster - Agendia
2018 SABCS FLEX Trials in Progress Poster - Agendia

2018 SABCS FLEX Trials in Progress Poster - Agendia
2018 SABCS FLEX Trials in Progress Poster - Agendia

plasmaMATCH Trial Shows Neratinib Activity in ERBB2 (HER2) Mutant  Metastatic Breast Cancer | Business Wire
plasmaMATCH Trial Shows Neratinib Activity in ERBB2 (HER2) Mutant Metastatic Breast Cancer | Business Wire

Video: ILC Mini-Symposium at 2017 San Antonio Breast Cancer Symposium - The  Lobular Breast Cancer Alliance
Video: ILC Mini-Symposium at 2017 San Antonio Breast Cancer Symposium - The Lobular Breast Cancer Alliance